ChemLex is an AI-for-science company founded in 2022 that develops technologies to radically accelerate chemical discovery for the pharmaceutical industry. At the core of its platform is a 24/7 autonomous chemistry system, an AI-powered, fully automated synthesis line that runs experiments around the clock and captures data in real time, making discovery faster, more cost-efficient, and more sustainable than traditional manual labs. Within three and a half years ChemLex grew to support more than 70 customers worldwide, including six of the world's top ten pharmaceutical companies. In December 2025 it announced a $45M funding round led by Granite Asia and established its global headquarters and self-driving laboratory in Singapore, alongside a memorandum of understanding with Singapore's Experimental Drug Development Centre to accelerate next-generation small-molecule discovery.